Center for Bioengineering and School of Electrical and Computer Engineering, University of Oklahoma, Norman, OK, USA 73019;
Center for Bioengineering and School of Electrical and Computer Engineering, University of Oklahoma, Norman, OK, USA 73019;
Department of Obstetrics Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA 73104;
Department of Obstetrics Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA 73104;
Department of Obstetrics Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA 73104;
Department of Radiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA 73104;
Department of Radiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA 73104;
School of Electrical and Computer Engineering, University of Oklahoma, Tulsa, OK, 74135;
Center for Bioengineering and School of Electrical and Computer Engineering, University of Oklahoma, Norman, OK, USA 73019;
Center for Bioengineering and School of Electrical and Computer Engineering, University of Oklahoma, Norman, OK, USA 73019;
Center for Bioengineering and School of Electrical and Computer Engineering, University of Oklahoma, Norman, OK, USA 73019;
Computer aided detection (CAD); ovarian cancer patients; metastatic tumor; tumor segmentation;
机译:初步化疗后循环肿瘤细胞在预测最初无法切除的转移性结直肠癌患者对进一步抗癌治疗的反应中的作用
机译:使用血清肿瘤标志物预测转移性或复发性乳腺癌患者对化疗的反应的预测模型的开发和验证。
机译:使用血清肿瘤标志物预测和评估转移性或复发性乳腺癌患者对化疗反应的预测模型的开发和验证
机译:提高转移性肿瘤分割的功效,促进卵巢癌患者对化疗的反应的早期预测
机译:阻断免疫抑制因子并利用肿瘤微环境内的营养供应:途径,以实现转移性黑素瘤患者的改善癌症免疫治疗疗效
机译:用新型合成抗体阻断TGF-β信号传导可限制免疫排斥并改善转移性卵巢癌模型的化疗反应
机译:具有新型合成抗体的TGF-β信号传导限制免疫排除并改善转移性卵巢癌模型中的化疗反应